Recent Finacing
Recent Raise
3-V Biosciences is a Menlo Park-based biopharmaceutical company discovering and developing therapeutics, including oral FASN inhibitor TVB-2640 for solid tumors and preclinical antiviral programs.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Sagimet Biosciences.
